Nitric oxide decreases the expression of endothelin-converting enzyme-1 through mRNA destabilization

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 31, Issue 11, 2011, Pages 2577-2585

  Raoch, Viviana ^a   Rodríguez Pascual, Fernando ^b,d,e   López Martínez, Vanesa ^a   Medrano Andrés, Diana ^a   Rodríguez Puyol, Manuel ^a,c,d   Lamas, Santiago ^b,d   Rodríguez Puyol, Diego ^d   López Ongil, Susana ^a,d  

^a HOSPITAL UNIVERSITARIO PRÍNCIPE DE ASTURIAS   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c UNIVERSITY OF ALCALÁ   (Spain)

^d Instituto Reina Sofía de Investigaciones Nefrológicas   (Spain)

^e Institut Català de Ciències Cardiovasculars   (Spain)

Author keywords

cyclic GMP; endothelial cells; endothelin converting enzyme 1; nitric oxide; protein kinase G

Indexed keywords

CYCLIC GMP DERIVATIVE; DIBUTYRYL CYCLIC GMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN CONVERTING ENZYME; GUANYLATE CYCLASE; LIPOPOLYSACCHARIDE; LUCIFERASE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE DONOR;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANIMALS; AORTA; ASPARTIC ACID ENDOPEPTIDASES; CATTLE; CELL LINE; COCULTURE TECHNIQUES; CYCLIC GMP; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; HEK293 CELLS; HUMANS; KIDNEY; MACROPHAGES; METALLOENDOPEPTIDASES; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE TYPE III; RATS, WISTAR; RNA, MESSENGER;

EID: 80054925953     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.232025     Document Type: Article

References (45)

1. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulindependent diabetes. J Clin Invest. 1992;90:2548-2554. (Pubitemid 23010077)
2. Calver A, Collier J, Moncada S, Vallance P. Effect of local intra-arterial NG-monomethyl-L-arginine in patients with hypertension: the nitric oxide dilator mechanism appears abnormal. J Hypertens. 1992; 10:1025-1031.
3. Ludmer PL, Selwyn AP, Shook TL, Wayne RR, Mudge GH, Alexander RW, Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 1986;315:1046-1051. (Pubitemid 17170620)
4. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 1992;19:918-925.
5. Yanagisawa M, Kurihara S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415. (Pubitemid 18090241)
6. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, de Wit D, Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell. 1994;78:473-485. (Pubitemid 24250811)
7. Turner AJ, Tanzawa K. Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 1997;11:355-364. (Pubitemid 27193940)
8. Muller L, Barret A, Etienne E, Meidan R, Valdenaire O, Corvol P, Tougard C. Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease. J Biol Chem. 2003;278:545-555. (Pubitemid 36043608)
9. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288: 373-376. (Pubitemid 11169009)
10. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987; 327:524-526. (Pubitemid 17085822)
11. Cardillo C, Kilcoyne CM, Cannon RO, Panza JA. Interactions between nitric oxide and endothelin in the regulation of vascular tone of human resistance vessels in vivo. Hypertension. 2000;35:1237-1241. (Pubitemid 30413657)
12. Rossi GP, Seccia TM, Nussdorfer GG. Reciprocal regulation of endothelin-1 and nitric oxide: relevance in the physiology and pathology of the cardiovascular system. Int Rev Cytol. 2001;209:241-272. (Pubitemid 32911032)
13. Kelly LK, Wedgwood S, Steinhorn RH, Black SM. Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am J Physiol Lung Cell Mol Physiol. 2004;286:984-991.
14. Blumberg FC, Wolf K, Sandner P, Lorenz C, Riegger GA, Pfeifer M. The NO donor molsidomine reduces endothelin-1 gene expression in chronic hypoxic rat lungs. Am J Physiol Lung Cell Mol Physiol. 2001;280: L258-L263.
15. Ohkita M, Takaoka M, Sugii M, Shiota Y, Nojiri R, Matsumura Y. The role of nuclear factor-kappa B in the regulation of endothelin-1 production by nitric oxide. Eur J Pharmacol. 2003;472:159-164. (Pubitemid 37271911)
16. Mather KJ, Lteif A, Steinberg HO, Baron AD. Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes. Diabetes. 2004;53:2060-2066. (Pubitemid 38970755)
17. Kourembanas S, McQuillan LP, Leung GK, Faller DV. Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest. 1993;92:99-104. (Pubitemid 23208985)
18. Ruschitzka F, Moehrlen U, Quaschning T, Lachat M, Noll G, Shaw S, Yang Z, Teupser D, Subkowski T, Turina MI, Lüscher TF. Tissue endothelin- converting enzyme activity correlates with cardiovascular risk factors in coronary artery disease. Circulation. 2000;102:1086-1092.
19. López-Ongil S, Saura M, Zaragoza C, Gonzalez-Santiago L, Rodríguez-Puyol M, Lowestein CJ, Rodríguez-Puyol D. Hydrogen peroxide regulation of bovine endothelin-converting enzyme-1. Free Radic Biol Med. 2002;32:406-413. (Pubitemid 34178350)
20. López-Ongil S, Senchak V, Saura M, Zaragoza C, Ames M, Ballermann B, Rodríguez-Puyol M, Rodríguez-Puyol D, Lowenstein CJ. Superoxide regulation of endothelin-converting enzyme. J Biol Chem. 2000;275: 26423-26427.
21. Martínez-Miguel P, Raoch V, Zaragoza C, Valdivielso JM, Rodríguez-Puyol M, Rodríguez-Puyol D, López-Ongil S. Endothelin converting enzyme-1 increases in atherosclerotic mice: potential role of oxidized low density lipoproteins. J Lipid Res. 2009;50:364-375.
22. López-Ongil S, Díez-Marqués ML, Griera M, Rodríguez-Puyol M. Rodríguez-Puyol D. Crosstalk between mesangial and endothelial cells: angiotensin II down-regulates endothelin-converting enzyme 1. Cell Physiol Biochem. 2005;15:135-144.
23. Raoch V, Martínez-Miguel P, Arribas-Gómez I, Rodríguez-Puyol M, Rodríguez-Puyol D, López-Ongil S. The peptide inhibitor CGS-26303 increases endothelin converting enzyme-1 expression in endothelial cells through accumulation of big endothelin-1. Br J Pharmacol. 2007;152: 313-322. (Pubitemid 47511258)
24. Saura M, Zaragoza C, Bao C, McMillan A, Lowenstein CJ. Interaction of interferon regulatory factor-1 and nuclear factor kappaB during activation of inducible nitric oxide synthase transcription. J Mol Biol. 1999;289: 459-471. (Pubitemid 29295117)
25. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159. (Pubitemid 17064313)
26. Rivero-Vilches FJ, de Frutos S, Saura M, Rodríguez-Puyol D, Rodríguez-Puyol M. Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-Iα activation by NO/cGMP. Am J Physiol Cell Physiol. 2003;285:C891-C898. (Pubitemid 37158814)
27. Gónzalez-Santiago L, López-Ongil S, Rodríguez-Puyol M, Rodríguez-Puyol D. Decreased nitric oxide synthesis in human endothelial cells cultured on type I collagen. Circ Res. 2002;90:539-545. (Pubitemid 34640903)
28. Rodríguez-Pascual F, Redondo-Horcajo M, Magán-Marchal N, Lagares D, Martínez-Ruiz A, Kleinert H, Lamas S. Glyceraldehyde-3- phosphate dehydrogenase regulates endothelin-1 expression by a novel, redoxsensitive mechanism involving mRNA stability. Mol Cell Biol. 2008;28: 7139-7155.
29. Reimunde FM, Castañares C, Redondo-Horcajo M, Lamas S, Rodríguez-Pascual F. Endothelin-1 expression is strongly repressed by AU-rich elements in the 3′-untranslated region of the gene. Biochem J. 2005;387: 763-772. (Pubitemid 40685711)
30. Saura M, Zaragoza C, Herranz B, Griera M, Diez-Marqués L, Rodríguez-Puyol D, Rodríguez-Puyol M. Nitric oxide regulates transforming growth factor-beta signalling in endothelial cells. Circ Res. 2005;97:1115-1123.
31. Browning DD, Mc Shane M, Marty C, Ye RD. Functional analysis of type 1alpha cGMP-dependent protein kinase using green fluorescent fusion proteins. J Biol Chem. 2001;276:13039-13048.
32. Valdenaire O, Rohrbacher E, Mattei MG. Organization of the gene encoding the human endothelin-converting enzyme (ECE-1). J Biol Chem. 1995;270:29794-29798. (Pubitemid 26001648)
33. Misquitta CM, Iyer VR, Werstiuk ES, Grover AK. The role of 3′-untranslated region (3′-UTR) mediated mRNA stability in cardiovascular pathophysiology. Moll Cell Biochem. 2001;224:53-67. (Pubitemid 32962652)
34. Ros J, Leivas A, Jimenez W, Morales M, Bosch-MarcéM, Arroyo V, Rivera F, Rodés J. Effect of bacterial lipopolysaccharide on endothelin-1 production in human vascular endothelial cells. J Hepatol. 1997;26: 81-87. (Pubitemid 27072608)
35. Uchida K, Uchida S, Nitta K, Yumura W, Nihei H. Regulated expression of endothelin converting enzymes in glomerular endothelial cells. J Am Soc Nephrol. 1997;8:580-585. (Pubitemid 27496540)
36. Ignarro LJ. Endothelium-derived nitric oxide: actions and properties. FASEB J. 1989;3:31-36. (Pubitemid 19042562)
37. Moro MA, Russel RJ, Cellek S, Lizasoain I, Su Y, Darely-Usmar VM, Radomski MW, Moncada S. cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA. 1996;93:1480-1485. (Pubitemid 26075149)
38. Wang GR, Zhu Y, Halunshka PV, Lincoln TM, Mendelsohn ME. Mechanism of platelet inhibition by nitric oxide: in vivo phosphorylation of thromboxane receptor by cyclic GMP-dependent protein kinase. Proc Natl Academic Sci USA. 1998;95:4888-4893. (Pubitemid 28208520)
39. Martínez-Ruíz A, Lamas S. Two decades of new concepts in nitric oxide signaling: from the discovery of a gas messenger to the mediation of nonenzymatic posttranslational modifications. IUBMB Life. 2009;61: 91-98.
40. Pilz RB, Casteel DE. Regulation of gene expression by cyclic GMP. Circ Res. 2003;93:1034-1046. (Pubitemid 37485034)
41. Shao R, Shi Z, Gotwals PJ, Koteliansky VE, George J, Rockey DC. Cell and molecular regulation of endothelin-1 production during hepatic wound healing. Mol Biol Cell. 2003;14:2327-2341. (Pubitemid 36724324)
42. Wu F, Yang Z, Li G. Role of specific microRNAs for endothelial function and angiogenesis. Biochem Biophys Res Commun. 2009;386:549-553.
43. Würdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO, Krichevsky AM. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell. 2008;14:382-393.
44. Li Y, Song YH, Li F, Yang T, Lu YW, Geng YJ. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun. 2009;381:81-83.
45. Jacobs AT, Ignarro LJ. Lipopolyssacharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. J Biol Chem. 2001;276: 47950-47957.